Share：
Share this content in WeChat
X
[Chinese][PDF]91081
• Review •
Present situations and prospects of magnetic resonance imaging in the evaluation of treatment response of cervical cancer
WU Ke  SUN Hongzan 

Cite this article as: Wu K, Sun HZ. Present situations and prospects of magnetic resonance imaging in the evaluation of treatment response of cervical cancer. Chin J Magn Reson Imaging, 2019, 10(10): 792-796. DOI:10.12015/issn.1674-8034.2019.10.016.


[Abstract] Cervical cancer is a common tumor in the female reproductive system. Radiotherapy and chemotherapy is considered as a standard treatment for locally advanced cervical cancer (LACC). At present, MRI have become the most commonly used examination for evaluating the treatment response of cervical cancer. MRI, not only provides anatomical information for the clinic, but also provides more valuable parameters by using functional imaging. It can evaluate the treatment response of radiotherapy and chemotherapy early and provide a base for clinically developing the optimal treatment plan. This article reviews the application of new MRI technology in the evaluation treatment response of cervical cancer.
[Keywords] uterine cervical neoplasms；magnetic resonance imaging；treatment response

WU Ke Department of Radiology, Shengjing Hospital of China Medical University, Shenyang 110004, China

SUN Hongzan * Department of Radiology, Shengjing Hospital of China Medical University, Shenyang 110004, China

*Corresponding to: Sun HZ, E-mail: sunhongzan@126.com

Conflicts of interest   None.

ACKNOWLEDGMENTS  This work was part of Liaoning Provincial Key Research and Development Guidance Program No. 2017225012
Received  2018-12-07
DOI: 10.12015/issn.1674-8034.2019.10.016
Cite this article as: Wu K, Sun HZ. Present situations and prospects of magnetic resonance imaging in the evaluation of treatment response of cervical cancer. Chin J Magn Reson Imaging, 2019, 10(10): 792-796. DOI:10.12015/issn.1674-8034.2019.10.016.

[1]
Zahra MA, Hollingsworth KG, Sala E, et al. Dynamic contrastenhanced MRI as a predictor of tumour response to radiotherapy. Lancet Oncol, 2007, 8(1): 63-74.
[2]
Hawighorst H, Knapstein PG, Knopp MV, et al. Uterine cervical carcinoma: Comparison of standard and pharmacokinetic analysis of time-intensity curves for assessment of tumor angiogenesis and patient survival. Cancer Res, 1998, 58(16): 3598-3602.
[3]
Punwani S. Contrast enhanced MR imaging of female pelvic cancers: established methods and emerging applications. Eur J Radiol, 2011, 78(1): 2-11.
[4]
Harry VN, Semple SI, Parkin DE, et al. Use of new imaging techniques to predict tumour response to therapy. Lancet Oncol, 2010, 11(1): 92-102.
[5]
Punwani S. Diffusion weighted imaging of female pelvic cancers: concepts and clinical applications. Eur J Radiol, 2011, 78(1): 21-29.
[6]
Zahra MA, Tan LT, Priest AN, et al. Semiquantitative and quantitative dynamic contrast-enhanced magnetic resonance imaging measurements predict radiation response in cervix cancer. Int J Radiat Oncol Biol Phys, 2009, 74(3): 766-773.
[7]
Mayr NA, Wang JZ, Zhang D, et al. Longitudinal changes in tumor perfusion pattern during the radiation therapy course and its clinical impact in cervical cancer. Int J Radiat Oncol Biol Phys, 2010, 77(2): 502-508.
[8]
Patterson DM, Padhani AR, Collins DJ. Technology insight: water diffusion MRI a potential new biomarker of response to cancer therapy. Nat Clin Pract Oncol, 2008, 5(4): 220-233 .
[9]
Naganawa S, Sato C, Kumada H, et al. Apparent diffusion coefficient in cervical cancer of the uterus: comparison with the normal uterine cervix. Eur Radiol, 2005, 15(1): 71-78.
[10]
Harry VN, Semple SI, Gilbert FJ, et al. Diffusion-weighted magnetic resonance imaging in the early detection of response to chemoradiation in cervical cancer. Gynecol Oncol, 2008, 111(2): 213-220．
[11]
Kuang F, Yan Z, Wang J, et al. The value of diffusion-weighted MRI to evaluate the response to radiochemotherapy for cervical cancer. Magn Reson Imaging, 2014, 32(4): 342-349.
[12]
Fu C, Feng X, Bian D, et al. Simultaneous changes of magnetic resonance diffusion-weighted imaging and pathological microstructure in locally advanced cervical cancer caused by neo-adjuvant chemotherapy. J Magn Reson Imaging, 2015, 42(2): 427-435.
[13]
Levy A, Caramella C, Chargari C, et al. Accuracy of diffusion-weighted echo-planar MR imaging and ADC mapping in the evaluation of residual cervical carcinoma after radiation therap. Gynecol Oncol, 2011, 123(1): 110-115.
[14]
Park JJ, Kim CK, Park BK. Prediction of disease progression following concurrent chemoradiotherapy for uterine cervical cancer: value of post-treatment diffusion-weighted imaging. Eur Radiol, 2016, 26(9): 3272-3279.
[15]
Jensen JH, Helpern JA, Ramani A, et al. Diffusional kurtosis imaging: the quantification of non-gaussian water diffusion by means of magnetic resonance imaging. Magn Reson Med, 2005, 53(6): 1432-1440.
[16]
Hui ES, Cheung MM, Qi L, et al. Advanced MR diffusion characterization of neural tissue using directional diffusion kurtosis analysis. Conf Proc IEEE Eng Med Biol Soc, 2008, 2008(30): 3941-3944.
[17]
Raab P, Hattingen E, Franz K, et al. Cerebral gliomas: diffusional kurtosis imaging analysis of microstructural differences. Radiology, 2010, 254(3): 876-881.
[18]
Nogueira L, Brandão S, Matos E, et al. Application of the diffusion kurtosis model for the study of breast lesions. Eur Radiol, 2014, 24(6): 1197-1203.
[19]
Padhani AR, Liu G, Koh DM, et al. Diffusion-weighted magnetic resonance imaging as a cancer biomarker: consensus and recommendations. Neoplasia (New York, NY), 2009, 11(2): 102-125.
[20]
Zhu L, Zhu L, Shi H, et al. Evaluating early response of cervical cancer under concurrent chemo-radiotherapy by intravoxel incoherent motion MR imaging. BMC Cancer, 2016, 16(1): 79.
[21]
Zhu L, Zhu LJ, Wang HH, et al. Predicting and early monitoring treatment efficiency of cervical cancer under concurrent chemoradiotherapy by intravoxel incoherent motion magnetic resonance imaging. J Comput Assist Tomogr, 2017, 41(3): 422-429.
[22]
Bartella L, Morris EA, Dershaw DD, et al. Proton MR spectroscopy with choline peak as malignancy marker improves positive predictive value for breast cancer diagnosis: preliminary study. Radiology, 2006, 239(3): 686-692.
[23]
Qi YX, Liu K, Yin J, et al. Evaluation of short- and long-term efficacy of chemoradiotherapy for advanced cervical cancer using HSP70 protein combined with multimodal MRI. J Cell Biochem, 2018, 119(4): 3017-3029.
[24]
Zhu M, Fischl AS, Trowbridge MA, et al. Reproducibility of total choline/water ratios in mouse U87MG xenograft tumors by 1H-MRS. J Magn Reson Imaging, 2012, 36(2): 459-467.
[25]
Hirsch NM, Toth V, Forschler A, et al. Technical considerations on the validity of blood oxygenationlevel-dependent-based MR assessment of vascular deoxygenation. NMR Biomed, 2014, 27(7): 853-862.
[26]
Mahajan A, Engineer R, Chopra S, et al. Role of 3T multiparametric- MRI with BOLD hypoxia imaging for diagnosis and post therapy response evaluation of postoperative recurrent cervical cancers. Eur J Radiol Open, 2016, 3(1): 20-33.
[27]
Kim CK, Park SY, Park BK, et al. Blood oxygenationlevel-dependent MR imaging as a predictor of therapeutic response toconcurrent chemoradiotherapy in cervical cancer: a preliminary experience. Eur Radiol, 2014, 24(7): 1514-1520.
[28]
Mahajan A, Goh V, Basu S, et al. Bench to bedside molecular functional imaging in translational cancer medicine: toimage or to imagine. Clin Radiol, 2015, 70(10): 1060-1082.
[29]
Jacobs MA, Ouwerkerk R, Wolff AC, et al. Multiparametric and multinuclear magnetic resonance imaging of human breast cancer: current applications. Technol Cancer Res Treat, 2004, 3(6): 543-550.
[30]
Ouwerkerk R, Jacobs MA, Macura KJ, et al. Elevated tissue sodium concentration in malignant breast lesions detected with non-invasive (23) Na MRI. Breast Cancer Res Treat, 2007, 106(2): 151-160.
[31]
Jacobs MA, Ouwerkerk R, Kamel I, et al. Proton, diffusion-weighted imaging, and sodium ((23)Na) MRI of uterine leiomyomata after MRguided high-intensity focused ultrasound: a preliminary study. J Magn Reson Imaging, 2009, 29(3): 649-656.
[32]
Ouwerkerk R, Bleich KB, Gillen JS, et al. Tissue sodium concentration in human brain tumors as measured with 23Na MR imaging. Radiology, 2003, 227(2): 529-537.
[33]
Zaric O, Pinker K, Zbyn S, et al. Quantitative sodium MR imaging at 7 T：Initial results and comparison with diffusion weighted imaging in patients with breast tumors. Radiology, 2016, 280(1): 39-48．
[34]
Rivlin M, Horev J, Tsarfaty I, et al. Molecular imaging of tumors and metastases using chemical exchange saturation transfer (CEST) MRI. Sei Rep, 2013, 36(3): 3045．
[35]
Asghar Butt S, Sogaard LV, Ardenkjaer-Larsen JH, et al. Monitoring mammary tumor progression and effect of tamoxifen treatment in MMTV-PymT using MRI and magnetic resonance spectroscopy with hyperpolarized[1-13C]pyruvate. Magn Reson Med, 2015, 73(1): 51-58.
[36]
van der Kemp WJM, Stehouwer BL, Boer VO, et al. Proton and phosphorus magnetic resonance spectroscopy of the healthy human breast at 7 T. NMR in Biomed, 2017, 30(2): e3684.

PREV Research progress in imageology of diabetic bone marrow microangiopathy
NEXT Application of different DWI models in the diagnosis of ovarian tumors
  


LINK


Tel & Fax: +8610-67113815    E-mail: editor@cjmri.cn